Last filing: Jan 26, 2026. Most recent sale before this period: May 15, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: May 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP, Chief Scientific Officer | May 29, 2012 | Jan 26, 2026 |
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 22, 2026, Vertex Pharmaceuticals: 11,194 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.